Advisory Research’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$595K Buy
21,629
+150
+0.7% +$4.93K 0.06% 125
2026
Q1
$800K Buy
21,479
+807
+4% +$33.3K 0.1% 118
2025
Q4
$967K Buy
20,672
+1,028
+5% +$44.5K 0.12% 111
2025
Q3
$823K Buy
+19,644
New +$864K 0.11% 117
2018
Q4
Sell
-7,310
Closed -$224K 373
2018
Q3
$224K Sell
7,310
-2,905
-28% -$88.2K ﹤0.01% 349
2018
Q2
$296K Buy
+10,215
New +$316K ﹤0.01% 349

Other funds holding G

Advisory Research's G Position: Q2 2026 in Review

Advisory Research increased its Genpact (G) stake by 0.7% in Q2 2026, buying an estimated $4.93K and bringing the position to 21,629 shares worth $595K. The position accounts for 0.06% of the portfolio, ranked #125.

Advisory Research first reported a position in G in Q2 2018 and has held it in 6 quarters since. The position peaked at $967K in Q4 2025. 480 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • Advisory Research held 21,629 shares of Genpact worth $595K as of Q2 2026.
  • Advisory Research bought 150 Genpact shares in Q2 2026, an estimated $4.93K.
  • Genpact made up 0.06% of Advisory Research's portfolio in Q2 2026, its #125 holding.
  • Advisory Research first reported a position in Genpact in Q2 2018 and has held it in 6 quarters since.
  • Advisory Research's Genpact position peaked at $967K in Q4 2025.
  • 480 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Advisory Research's 13F filing for Q2 2026, filed 13 Aug 2026.